by Isabella Backman – Yale School of Medicine –
CAR T-cell therapy, officially known as chimeric antigen receptor (CAR) T-cell therapy, is among the newest cancer treatments that harness our immune system— the powerful network of cells, tissues, and organs that fights off disease and infection. By synthetically engineering immune cells called T cells to precisely target malignant tumor cells, this method has the potential to revolutionize cancer treatment and more.
“CAR T-cell therapy is showing great promise, and because of how powerful this approach is and how unlimited I believe its potential is, we will hopefully one day be able to target all tumor types.” said Samuel Katz, MD, PhD
